Plasma cell leukemia (PCL) is a rare and aggressive form of leukemia that develops from plasma cells — a type of white blood cell that normally helps fight infections by making antibodies.
There are two types of PCL:
- Primary PCL — occurs in people who have never had another blood cancer before
- Secondary PCL — develops Show Full Answer
Plasma cell leukemia (PCL) is a rare and aggressive form of leukemia that develops from plasma cells — a type of white blood cell that normally helps fight infections by making antibodies.
There are two types of PCL:
- Primary PCL — occurs in people who have never had another blood cancer before
- Secondary PCL — develops in people who previously had multiple myeloma (about 1–4% of those cases)
PCL is considered more advanced and faster-growing than multiple myeloma, so treatment is usually started right away and can be more aggressive. Common symptoms to be aware of include:
- Bone pain or fractures
- Extreme tiredness
- Frequent infections
- Bleeding problems
- Enlarged spleen or liver
Treatment typically happens in three phases — induction (getting leukemia under control), consolidation (clearing remaining cancer cells), and maintenance (keeping cancer from returning). Options can include chemotherapy, immunotherapy, targeted therapies, and stem cell transplantation.
It's always best to work closely with your care team to find the right treatment plan for your specific situation.
AI-generated responses are not a substitute for medical advice. These services are not intended to
diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.
Plasma Cell Leukemia: An Overview
September 2
Join
Your Privacy Choices
